Skip to main content
SpringerLink
Log in

Lymphoid and Hematopoietic Tumors of the Breast

  • Chapter
  • First Online:
A Comprehensive Guide to Core Needle Biopsies of the Breast

  • 1419 Accesses

Abstract

Hematopoietic tumors of the breast are very rare. Non-Hodgkin lymphoma is the most frequently encountered disease subtype and accounts for less than 1 % of all non-Hodgkin lymphomas. Primary lymphoma of the breast is less common than secondary breast involvement by disseminated lymphoma and constitutes approximately 0.5 % of all malignant breast lesions. The majority of both primary and secondary breast lymphomas correspond to diffuse large B-cell lymphoma, followed by low-grade B-cell lymphomas, such as extranodal marginal zone lymphoma and follicular lymphoma. Chronic lymphocytic leukemia, mantle cell lymphoma, peripheral T-cell lymphoma, and lymphoblastic lymphoma are very rare and typically present in patients with evidence of systemic disease. Burkitt lymphoma of the breast is significantly associated with African ethnicity, young age and pregnancy or lactation. Classical Hodgkin lymphoma of the breast virtually always represents either direct extension from axillary or mediastinal lymph nodes or is a manifestation of systemic disease. Primary breast lymphoma usually presents as a large painless breast mass, which is clinically and radiographically indistinguishable from breast carcinoma. The diagnostic yield of a core needle biopsy is approximately 50 % and is higher for high-grade lymphoma, compared to low-grade lymphoma. Immunophenotypic evaluation is mandatory in order to correctly diagnose and subtype lymphoma. Polymerase chain reaction (PCR) analysis demonstration of clonal immunoglobulin and T-cell receptor gene rearrangements have been successfully used to determine the lineage and clonality of lymphoma in challenging cases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brogi E, Harris NL. Lymphomas of the breast: pathology and clinical behavior. Semin Oncol. 1999;26(3):357–64.

    CAS  PubMed  Google Scholar 

  2. Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP. Lymphomas of the breast: primary and secondary involvement. Cancer. 2002;94(1):6–13.

    Article  PubMed  Google Scholar 

  3. Farinha P, Andre S, Cabecadas J, Soares J. High frequency of MALT lymphoma in a series of 14 cases of primary breast lymphoma. Appl Immunohistochem Mol Morphol. 2002;10(2): 115–20.

    PubMed  Google Scholar 

  4. Hugh JC, Jackson FI, Hanson J, Poppema S. Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer. 1990;66(12):2602–11.

    Article  CAS  PubMed  Google Scholar 

  5. Talwalkar SS, Miranda RN, Valbuena JR, Routbort MJ, Martin AW, Medeiros LJ. Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol. 2008;32(9):1299–309.

    Article  PubMed  Google Scholar 

  6. Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29(6):1705–12.

    Article  CAS  PubMed  Google Scholar 

  7. Barista I, Baltali E, Tekuzman G, et al. Primary breast lymphomas—a retrospective analysis of twelve cases. Acta Oncol. 2000;39(2):135–9.

    Article  CAS  PubMed  Google Scholar 

  8. Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin’s lymphomas of the female breast. Cancer. 1992;69(3):725–35.

    Article  CAS  PubMed  Google Scholar 

  9. Julen O, Dellacasa I, Pelte MF, et al. Primary breast lymphomas. Rare Tumors. 2009;1(1):e14.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Knowles DM. The extranodal lymphoid infiltrate: a diagnostic dilemma. Semin Diagn Pathol. 1985;2(3):147–51.

    Google Scholar 

  11. Burke JS. Histologic criteria for distinguishing between benign and malignant extranodal lymphoid infiltrates. Semin Diagn Pathol. 1985;2(3):152–62.

    CAS  PubMed  Google Scholar 

  12. Knowles DM, Jakobiec FA. Cell marker analysis of extranodal lymphoid infiltrates: to what extent does the determination of mono- or polyclonality resolve the diagnostic dilemma of malignant lymphoma v pseudolymphoma in an extranodal site? Semin Diagn Pathol. 1985;2(3):163–8.

    Google Scholar 

  13. Knowles DM, Halper JP, Jakobiec FA. The immunologic characterization of 40 extranodal lymphoid infiltrates: usefulness in distinguishing between benign pseudolymphoma and malignant lymphoma. Cancer. 1982;49(11):2321–35.

    Google Scholar 

  14. Knowles DM. Immunophenotypic and immunogenotypic approaches useful in distinguishing benign and malignant lymphoid proliferations. Semin Oncol. 1993;20(6):583–610.

    CAS  PubMed  Google Scholar 

  15. Knowles DM, Jakobiec FA, McNally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol. 1990;21(9):959–73.

    Article  CAS  PubMed  Google Scholar 

  16. Seidman JG, Leder P. The arrangement and rearrangement of antibody genes. Nature. 1978;276(5690):790–5.

    Article  CAS  PubMed  Google Scholar 

  17. Tonegawa S. Somatic generation of antibody diversity. Nature. 1983;302(5909):575–81.

    Article  CAS  PubMed  Google Scholar 

  18. Yanagi Y, Yoshikai Y, Leggett K, Clark SP, Aleksander I, Mak TW. A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains. Nature. 1984; 308(5955):145–9.

    Article  CAS  PubMed  Google Scholar 

  19. Pelicci PG, Knowles DM, Arlin ZA, et al. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med. 1986;164(6): 2049–60.

    Google Scholar 

  20. Neri A, Jakobiec FA, Pelicci PG, Dalla-Favera R, Knowles DM. Immunoglobulin and T cell receptor beta chain gene rearrangement analysis of ocular adnexal lymphoid neoplasms: clinical and biologic implications. Blood. 1987;70(5):1519–29.

    Google Scholar 

  21. Knowles DM, Athan E, Ubriaco A, et al. Extranodal noncutaneous lymphoid hyperplasias represent a continuous spectrum of B-cell neoplasia: demonstration by molecular genetic analysis. Blood. 1989;73(6):1635–45.

    CAS  PubMed  Google Scholar 

  22. Isaacson PG, Norton AJ. Extranodal lymphomas. Edinbirgh: Churchill Livingstone; 1994.

    Google Scholar 

  23. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84(5):1361–92.

    CAS  PubMed  Google Scholar 

  24. Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO classification of tumours of haematopoietic and lymphoid tissues. In: Bosman FT, Lakhani SR, Ohgaki H, editors. World Health Organization classification of tumours. 4th ed. Lyon: IARC; 2008.

    Google Scholar 

  25. Kurtin PJ. How do you distinguish benign from malignant extranodal small B-cell proliferations? Am J Clin Pathol. 1999;111(1 Suppl 1):S119–25.

    CAS  PubMed  Google Scholar 

  26. Caon J, Wai ES, Hart J, et al. Treatment and outcomes of primary breast lymphoma. Clin Breast Cancer. 2012;12(6):412–9.

    Article  PubMed  Google Scholar 

  27. Cheah CY, Campbell BA, Seymour JF. Primary breast lymphoma. Cancer Treat Rev. 2014;40(8):900–8.

    Article  PubMed  Google Scholar 

  28. Talwalkar SS, Valbuena JR, Abruzzo LV, et al. MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast. Mod Pathol. 2006;19(11):1402–8.

    CAS  PubMed  Google Scholar 

  29. Jung SP, Han KM, Kim SJ, Nam SJ, Bae JW, Lee JE. Primary follicular lymphoma in a male breast: a case report. Cancer Res Treat. 2014;46(1):104–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Mpallas G, Simatos G, Tasidou A, et al. Primary breast lymphoma in a male patient. Breast. 2004;13(5):436–8.

    Article  CAS  PubMed  Google Scholar 

  31. Rathod J, Taori K, Disawal A, et al. A rare case of male primary breast lymphoma. J Breast Cancer. 2011;14(4):333–6.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Lokesh K, Sathyanarayanan V, Lakshmaiah K, et al. Primary breast lymphoma in males-a report of two cases with a review of the literature. Ecancermedicalscience. 2013;7:347.

    PubMed  PubMed Central  Google Scholar 

  33. Aviles A, Delgado S, Nambo MJ, Neri N, Murillo E, Cleto S. Primary breast lymphoma: results of a controlled clinical trial. Oncology. 2005;69(3):256–60.

    Article  PubMed  Google Scholar 

  34. Jeanneret-Sozzi W, Taghian A, Epelbaum R, et al. Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre rare cancer network study. BMC Cancer. 2008;8:86.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Jennings WC, Baker RS, Murray SS, et al. Primary breast lymphoma: the role of mastectomy and the importance of lymph node status. Ann Surg. 2007;245(5):784–9.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Jung SP, Kim M, Han KM, et al. Primary breast lymphoma: a single institution’s experience. J Korean Surg Soc. 2013;84(5):267–72.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Martinelli G, Ryan G, Seymour JF, et al. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2009;20(12):1993–9.

    Article  CAS  PubMed  Google Scholar 

  38. Ou CW, Shih LY, Wang PN, et al. Primary breast lymphoma: a single-institute experience in Taiwan. Biomed J. 2014;37(5): 321–5.

    Article  PubMed  Google Scholar 

  39. Seker M, Bilici A, Ustaalioglu BO, et al. Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast. Arch Gynecol Obstet. 2011;284(2):405–9.

    Article  PubMed  Google Scholar 

  40. Shao YB, Sun XF, He YN, Liu CJ, Liu H. Clinicopathological features of thirty patients with primary breast lymphoma and review of the literature. Med Oncol. 2015;32(2):448.

    Article  CAS  PubMed  Google Scholar 

  41. Yhim HY, Kang HJ, Choi YH, et al. Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study. BMC Cancer. 2010;10:321.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hosein PJ, Maragulia JC, Salzberg MP, et al. A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era. Br J Haematol. 2014;165(3):358–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Ryan G, Martinelli G, Kuper-Hommel M, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2008;19(2):233–41.

    Article  CAS  PubMed  Google Scholar 

  44. Fukuhara S, Watanabe T, Munakata W, et al. Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution. Eur J Haematol. 2011;87(5):434–40.

    Article  PubMed  Google Scholar 

  45. Ganjoo K, Advani R, Mariappan MR, McMillan A, Horning S. Non-Hodgkin lymphoma of the breast. Cancer. 2007;110(1): 25–30.

    Article  PubMed  Google Scholar 

  46. Sabate JM, Gomez A, Torrubia S, et al. Lymphoma of the breast: clinical and radiologic features with pathologic correlation in 28 patients. Breast J. 2002;8(5):294–304.

    Article  CAS  PubMed  Google Scholar 

  47. Lyou CY, Yang SK, Choe DH, Lee BH, Kim KH. Mammographic and sonographic findings of primary breast lymphoma. Clin Imaging. 2007;31(4):234–8.

    Article  PubMed  Google Scholar 

  48. Fruchart C, Denoux Y, Chasle J, et al. High grade primary breast lymphoma: is it a different clinical entity? Breast Cancer Res Treat. 2005;93(3):191–8.

    Article  PubMed  Google Scholar 

  49. Niitsu N, Okamoto M, Nakamine H, Hirano M. Clinicopathologic features and treatment outcome of primary breast diffuse large B-cell lymphoma. Leuk Res. 2008;32(12):1837–41.

    Article  PubMed  Google Scholar 

  50. Yoshida S, Nakamura N, Sasaki Y, et al. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype. Mod Pathol. 2005;18(3):398–405.

    Article  CAS  PubMed  Google Scholar 

  51. De Paepe P, Achten R, Verhoef G, et al. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas. J Clin Oncol. 2005;23(28):7060–8.

    Article  PubMed  Google Scholar 

  52. Ribrag V, Bibeau F, El Weshi A, et al. Primary breast lymphoma: a report of 20 cases. Br J Haematol. 2001;115(2):253–6.

    Article  CAS  PubMed  Google Scholar 

  53. Monteiro M, Duarte I, Cabecadas J, Orvalho ML. Intravascular large B-cell lymphoma of the breast. Breast. 2005;14(1):75–8.

    Article  CAS  PubMed  Google Scholar 

  54. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503–11.

    Article  CAS  PubMed  Google Scholar 

  55. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–82.

    Article  CAS  PubMed  Google Scholar 

  56. Choi WW, Weisenburger DD, Greiner TC, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009;15(17): 5494–502.

    Article  CAS  PubMed  Google Scholar 

  57. Aviles A, Neri N, Nambo MJ. The role of genotype in 104 cases of diffuse large B-cell lymphoma primary of breast. Am J Clin Oncol. 2012;35(2):126–9.

    Article  CAS  PubMed  Google Scholar 

  58. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol. 1994; 25(10):1020–9.

    Article  CAS  PubMed  Google Scholar 

  59. Molina TJ, Lin P, Swerdlow SH, Cook JR. Marginal zone lymphomas with plasmacytic differentiation and related disorders. Am J Clin Pathol. 2011;136(2):211–25.

    Article  PubMed  Google Scholar 

  60. Horowitz NA, Benyamini N, Wohlfart K, Brenner B, Avivi I. Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: a systematic review. Lancet Oncol. 2013;14(7): e275–82.

    Article  PubMed  Google Scholar 

  61. Janbabai G, Kayedimajd S, Alian S, Naghshvar F, Rashidi M, Farazmandfar T. Bilateral breast swelling in a 23-year-old woman with Burkitt lymphoma. J Res Med Sci. 2012;17(12):1188–91.

    PubMed  PubMed Central  Google Scholar 

  62. Negahban S, Ahmadi N, Oryan A, et al. Primary bilateral Burkitt lymphoma of the lactating breast: a case report and review of the literature. Mol Diagn Ther. 2010;14(4):243–50.

    Article  PubMed  Google Scholar 

  63. Lingohr P, Eidt S, Rheinwalt KP. A 12-year-old girl presenting with bilateral gigantic Burkitt’s lymphoma of the breast. Arch Gynecol Obstet. 2009;279(5):743–6.

    Article  PubMed  Google Scholar 

  64. Miranda RN, Aladily TN, Prince HM, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014;32(2):114–20.

    Article  PubMed  Google Scholar 

  65. Aladily TN, Medeiros LJ, Amin MB, et al. Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol. 2012;36(7):1000–8.

    Article  PubMed  Google Scholar 

  66. Fritzsche FR, Pahl S, Petersen I, et al. Anaplastic large-cell non-Hodgkin’s lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer—a case report. Virchows Arch. 2006;449(5):561–4.

    Article  PubMed  Google Scholar 

  67. Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol. 2008;21(4):455–63.

    Article  CAS  PubMed  Google Scholar 

  68. Farkash EA, Ferry JA, Harris NL, et al. Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls. J Hematop. 2009;2(4):237–44.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Sahoo S, Rosen PP, Feddersen RM, Viswanatha DS, Clark DA, Chadburn A. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature. Arch Pathol Lab Med. 2003;127(3):e115–8.

    PubMed  Google Scholar 

  70. Muroya D, Toh U, Iwakuma N, et al. Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case. Surg Today. 2015;45(1):115–20.

    Article  PubMed  Google Scholar 

  71. Mattia AR, Ferry JA, Harris NL. Breast lymphoma. A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. Am J Surg Pathol. 1993;17(6):574–87.

    Article  CAS  PubMed  Google Scholar 

  72. Gualco G, Chioato L, Harrington Jr WJ, Weiss LM, Bacchi CE. Primary and secondary T-cell lymphomas of the breast: clinico-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol. 2009;17(4):301–6.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Lin YC, Tsai CH, Wu JS, et al. Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast—a review of 42 primary and secondary cases in Taiwanese patients. Leuk Lymphoma. 2009;50(6):918–24.

    Article  CAS  PubMed  Google Scholar 

  74. Arber DA, Simpson JF, Weiss LM, Rappaport H. Non-Hodgkin’s lymphoma involving the breast. Am J Surg Pathol. 1994;18(3): 288–95.

    Article  CAS  PubMed  Google Scholar 

  75. Ely KA, Tse G, Simpson JF, Clarfeld R, Page DL. Diabetic mastopathy. A clinicopathologic review. Am J Clin Pathol. 2000; 113(4):541–5.

    Article  CAS  PubMed  Google Scholar 

  76. Oba M, Sasaki M, Ii T, et al. A case of lymphocytic mastopathy requiring differential diagnosis from primary breast lymphoma. Breast Cancer. 2009;16(2):141–6.

    Article  PubMed  Google Scholar 

  77. Zack JR, Trevisan SG, Gupta M. Primary breast lymphoma originating in a benign intramammary lymph node. AJR Am J Roentgenol. 2001;177(1):177–8.

    Article  CAS  PubMed  Google Scholar 

  78. Antoniou SA, Antoniou GA, Makridis C, Spyrou A, Malkotsi T. Bilateral primary breast lymphoma masquerading as lactating mastitis. Eur J Obstet Gynecol Reprod Biol. 2010;152(1):111–2.

    Article  PubMed  Google Scholar 

  79. Kirkpatrick AW, Bailey DJ, Weizel HA. Bilateral primary breast lymphoma in pregnancy: a case report and literature review. Can J Surg. 1996;39(4):333–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  80. Teras LR, Patel AV, Hildebrand JS, Gapstur SM. Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort. Leuk Lymphoma. 2013;54(4):720–5.

    Article  CAS  PubMed  Google Scholar 

  81. Yakimchuk K, Hasni MS, Guan J, Chao MP, Sander B, Okret S. Inhibition of lymphoma vascularization and dissemination by estrogen receptor beta agonists. Blood. 2014;123(13):2054–61.

    Article  CAS  PubMed  Google Scholar 

  82. Yakimchuk K, Iravani M, Hasni MS, et al. Effect of ligand-activated estrogen receptor beta on lymphoma growth in vitro and in vivo. Leukemia. 2011;25(7):1103–10.

    Article  CAS  PubMed  Google Scholar 

  83. Yakimchuk K, Jondal M, Okret S. Estrogen receptor alpha and beta in the normal immune system and in lymphoid malignancies. Mol Cell Endocrinol. 2013;375(1–2):121–9.

    Article  CAS  PubMed  Google Scholar 

  84. Zhao S, Zhang QY, Ma WJ, et al. Analysis of 31 cases of primary breast lymphoma: the effect of nodal involvement and microvascular density. Clin Lymphoma Myeloma Leuk. 2011;11(1):33–7.

    Article  PubMed  Google Scholar 

  85. Guo HY, Zhao XM, Li J, Hu XC. Primary non-Hodgkin’s lymphoma of the breast: eight-year follow-up experience. Int J Hematol. 2008;87(5):491–7.

    Article  PubMed  Google Scholar 

  86. Wong WW, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic experience. J Surg Oncol. 2002;80(1):19–25. discussion 26.

    Article  PubMed  Google Scholar 

  87. Gualco G, Bacchi CE. B-cell and T-cell lymphomas of the breast: clinical—pathological features of 53 cases. Int J Surg Pathol. 2008;16(4):407–13.

    Article  PubMed  Google Scholar 

  88. Lin Y, Govindan R, Hess JL. Malignant hematopoietic breast tumors. Am J Clin Pathol. 1997;107(2):177–86.

    Article  CAS  PubMed  Google Scholar 

  89. Stewart RL, Dell CM, Samayoa L. Myeloid sarcoma of the breast misdiagnosed as poorly differentiated mammary carcinoma with lobular features. Breast J. 2015;21(2):192–3.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Nalwa A, Nath D, Suri V, Jamaluddin MA, Srivastava A. Myeloid sarcoma of the breast in an aleukemic patient: a rare entity in an uncommon location. Malays J Pathol. 2015;37(1):63–6.

    PubMed  Google Scholar 

  91. Huang Q, Reddi D, Chu P, Snyder DS, Weisenburger DD. Clinical and pathologic analysis of extramedullary tumors after hematopoietic stem cell transplantation. Hum Pathol. 2014;45(12):2404–10.

    Article  PubMed  Google Scholar 

  92. Delporte F, Voorhoopf LJ, Lodewyck T, De Paepe P. Primary granulocytic sarcoma of the breast: a case report and review of the literature. Eur J Gynaecol Oncol. 2011;32(4):435–8.

    CAS  PubMed  Google Scholar 

  93. Campidelli C, Agostinelli C, Stitson R, Pileri SA. Myeloid sarcoma: extramedullary manifestation of myeloid disorders. Am J Clin Pathol. 2009;132(3):426–37.

    Article  PubMed  Google Scholar 

  94. Pileri SA, Ascani S, Cox MC, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21(2):340–50.

    Article  CAS  PubMed  Google Scholar 

  95. Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41(1):1–29.

    Article  CAS  PubMed  Google Scholar 

  96. Dalia S, Jaglal M, Chervenick P, Cualing H, Sokol L. Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years. Cancers (Basel). 2014;6(4):2275–95.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, Starr 715, 525 East 68th Street, New York, NY, 10065, USA

    Julia Turbiner Geyer M.D.

Authors
  1. Julia Turbiner Geyer M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julia Turbiner Geyer M.D. .

Editor information

Editors and Affiliations

  1. New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA

    Sandra J. Shin

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Geyer, J.T. (2016). Lymphoid and Hematopoietic Tumors of the Breast. In: Shin, S. (eds) A Comprehensive Guide to Core Needle Biopsies of the Breast . Springer, Cham. https://doi.org/10.1007/978-3-319-26291-8_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26291-8_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26289-5

  • Online ISBN: 978-3-319-26291-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation